Drug maker posts a loss but expects higher sales
549383
THE REGION Genzyme Corp. , maker of enzyme therapies for rare diseases, had a loss in the fourth quarter on acquisition costs but expects higher sales in 2007. The net loss was $268.2 million, or $1.02 a share, versus net income of $106.6 million, or 39 cents, a year earlier, the Cambridge company said. Profit excluding some costs beat analyst ...
97474
YESTERDAY Close $32.94 Change +$0.63 52-WEEK High $45.38 Low $25.61 Biotechnology company Vertex Pharmaceuticals Inc. said its loss widened in the third quarter, as it invested more in its hepatitis C drug candidate and relied less on collaborative funding.
469619
The world's largest drug firm reports strong  profits despite a fall in Viagra sales  but  it warns that next year's profits will be hit by the expiry of  patents.
159667
Pharmacy chain operator Rite Aid Corp.  RAD.N on Thursday posted a quarterly loss, compared with a  profit in the same year-earlier quarter, and cut its full-year  outlook, citing worse-than-expected sales.
159240
Elan Corp. PLC, Ireland&#39;s largest pharmaceutical firm, reported widening third-quarter losses Thursday but predicted a return to profit in 2006.
494872
Boston Scientific Corp. , the state's largest life-science company, lost $3.6 billion last year thanks to its expensive acquisition of heart-device maker Guidant Corp. , and executives said yesterday they weren't certain when sales of its most important products would begin to recover from their slump.
314038
Leading shares closed lower, as losses amongst heavy weight pharmaceutical makers hit both sides of the Atlantic, dealers said.
29498
Despite its fourth-quarter loss, the pharmaceutical giantâs results topped Wall Street estimates, and its shares rose more than 5 percent.
363785
Sales of the multiple sclerosis drug are picking up, but probably can't grow into the stock's valuation.
591032
The maker of fiber optic networking gear said it had sharply narrowed its fourth-quarter loss, but its sales forecast fell short of Wall Street estimates.
358404
Schering-Plough Corp  reported on Monday that third-quarter profit and sales rose, but still fell short of estimates, sending shares down 13 percent amid concerns about its flagship cholesterol drugs.
336343
Merck posted a $1.63 billion fourth-quarter loss on Wednesday as charges for its Vioxx litigation settlement dragged down results and share prices.
463698
The French pharmaceutical company has lost a crucial slice of the U.S. market and seen its shares tumble. Talks of an acquisition could be food for thought.
738503
YESTERDAY Close $54.64 Change +$1.53 52-WEEK High $55.14 Low $42.29 Merck &amp; Co., the third-largest US drug maker, reported a 63 percent increase in earnings and raised its forecast for the year after a vaccine for cervical cancer and a new pill for diabetes drove sales higher.
559190
Wyeth on Monday reported a quarterly  loss due to a $4.5 billion charge for its recalled "fen-phen"  diet drugs and warned of disappointing profit for 2005, sending  its shares down almost 8 percent.
82904
SHANGHAI -- Looking at the facts, the past year seems to have been disastrous for Worldbest Pharmaceutical.  First, there were reports of accounting irregularities and exaggerated profit. Half the managers were fired. Then, in the summer, six people died and at least 80 fell ill after receiving an antibiotic injection manufactured by a subsidiary. Most recently, the company warned investors that it was likely to report its third consecutive year of losses....
699925
The world's largest drug company reports strong third-quarter profits but warns that next years profits will be hit by the expiry of  patents.